These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16834932)

  • 1. Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder.
    Hou JQ; He J; Wen DG; Chen ZX; Zeng J
    Chin Med J (Engl); 2006 Jul; 119(13):1118-20. PubMed ID: 16834932
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas.
    Kitsukawa S; Aoyagi T; Noda K; Ito T; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T
    Hinyokika Kiyo; 2008 Feb; 54(2):101-6. PubMed ID: 18323166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
    Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
    J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.
    Al-Maghrebi M; Kehinde EO; Kapila K; Anim JT
    Med Princ Pract; 2012; 21(3):295-7. PubMed ID: 22236881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
    Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
    J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of hepatoma-up-regulated protein expression in patients with urinary bladder transitional cell carcinoma.
    Huang YL; Chiu AW; Huan SK; Wang YC; Ju JP; Lu CL
    Anticancer Res; 2003; 23(3B):2729-33. PubMed ID: 12894566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
    Xie XY; Yang X; Zhang JH; Liu ZJ
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
    Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
    Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of survivin mRNA in urine of patients with superficial urothelial cell carcinomas.
    Pina-Cabral L; Santos L; Mesquita B; Amaro T; Magalhães S; Criado B
    Clin Transl Oncol; 2007 Nov; 9(11):731-6. PubMed ID: 18055328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W; Xu Z
    Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine detection of survivin and diagnosis of bladder cancer.
    Moore M
    J Insur Med; 2001; 33(2):202-3. PubMed ID: 11510521
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of urinary proepithelin as a potential biomarker for bladder cancer detection and prognosis in Egyptian patients.
    Selmy MA; Ibrahim GH; El Serafi TI; Ghobeish AA
    Cancer Biomark; 2010; 7(3):163-70. PubMed ID: 21263192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
    Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
    Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
    Shariat SF; Ashfaq R; Karakiewicz PI; Saeedi O; Sagalowsky AI; Lotan Y
    Cancer; 2007 Mar; 109(6):1106-13. PubMed ID: 17311310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations on the use of urine markers for bladder cancer.
    van Rhijn BW
    Eur Urol; 2008 May; 53(5):880-1. PubMed ID: 18222604
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin.
    Kenney DM; Geschwindt RD; Kary MR; Linic JM; Sardesai NY; Li ZQ
    Tumour Biol; 2007; 28(2):57-62. PubMed ID: 17259754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.